Ember LifeSciences Raises $10.5M in Additional Series A Funding

Deal Summary

Ember LifeSciences announced an additional $10.5 million Series A funding round, with strategic investors Amgen Ventures and TDF Ventures. The capital will support the company's cold‑chain technology platform for life‑science applications. The round was disclosed on May 27, 2026.